Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23896)

• Formulation Name: Siponimod 2mg tablet
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Siponimod	(DM2R86O)	Multiple sclerosis	8A40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Crospovidone	(E00626)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Glyceryl behenate	(E00481)	5362585	Binding agent; Coating agent; Flavoring agent; Modified-release agent; Viscosity-controlling agent; lubricant
Haematite red	(E00236)	14833	Colorant
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Polyvinyl alcohol	(E00666)	Not Available	Coating agent; Emulsion stabilizing agent; Film/Membrane-forming agent
Soybean lecithin	(E00637)	Not Available	Other agent
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Xanthan gum	(E00694)	Not Available	Bioadhesive material; Emulsifying agent; Gelling agent; Modified-release agent; Suspending agent; Viscosity-controlling agent